Glaxo set to profit from US ruling

Glaxo Wellcome stands to make hundreds of millions in extra sales this year after a decision by the US drug regulator to award exclusive rights to a Canadian group to sell a generic version of its blockbuster ulcer drug, Zantac in the US.

The decision grants Toronto-based Genpharm exclusive rights to the huge US ranitidine (generic Zantac) market between 25 July - the day Glaxo's branded Zantac loses its US patent - and August 29th. This will keep hordes of other generic companies out of the market, allowing Glaxo and Genpharm a short, but highly profitable monopoly.

Glaxo, which currently makes pounds 3m a day from US Zantac sales, faced losing 80 per cent of that market when other companies flooded in on July 25th. With only one generic in the market, the Zantac brand price would not fall as far and fast as had been feared. Analysts say Genpharm will want to keep market prices high, as it is being sued by Glaxo for infringing the Zantac patent. Anthony Colletta, analyst at Hoare Govett said: "Genpharm will want to make profits fast. If it loses the case, it will have to pay triple in compensation back to Glaxo."

Though Glaxo said it is "not in a position to evaluate" the effect of the ruling on Zantac sales, it stands to benefit in other ways too. As part of a settlement of disputes over the validity of ranitidine, Glaxo recently signed an agreement, for which it got a reputed pounds 75m, giving another generic group Novopharm the right to sell ranitidine from 10th July, 15 days ahead of the Zantac patent expiry. If the ruling granting Genpharm exclusive rights is upheld and Novopharm is not the first in, Glaxo will have an extra 15 days to sell Zantac unopposed. Novopharm is appealing vigorously against the ruling.

One loser in all this could be Holliday Chemicals, the world's biggest supplier of ranitidine. Though Holliday does supply other groups including Genpharm, its biggest and exclusive licence is with Novopharm. If Novopharm loses the all-important right to be first into the market - which means it can tie up customers at good prices - Hollidays sales would suffer. Holliday's share price has risen steeply on prospects of a huge rise in ranitidine sales. Michael Eastwood from Kleinwort Benson, says that pounds 4m of his pounds 23m 1997 profit forecast for Holliday is on the potential of the US ranitidine market alone. A more serious issue is if Holliday loses a patent infringement case brought by Glaxo against its Spanish subsidiary Uquifa which manufactures rantidine. Should it lose, supplies of ranitidine would dry up and Holliday would suffer. Glaxo, by contrast, would have two years of relatively unopposed Zantac sales.

Start your day with The Independent, sign up for daily news emails
News
ebookA unique anthology of reporting and analysis of a crucial period of history
News
peopleMathematician John Nash inspired the film Beautiful Mind
News
Richard Blair is concerned the trenches are falling into disrepair
newsGeorge Orwell's son wants to save war site that inspired book
Life and Style
Audrey Hepburn with Hubert De Givenchy, whose well-cut black tuxedo is a 'timeless look'
fashionIt may be a paradox, but the industry loves it
Arts and Entertainment
The pair in their heyday in 1967
music
Life and Style
fashionFrom bathing dresses in the twenties to modern bikinis
Latest stories from i100
Have you tried new the Independent Digital Edition apps?
Independent Dating
and  

By clicking 'Search' you
are agreeing to our
Terms of Use.

iJobs Job Widget
iJobs Money & Business

Guru Careers: Software Developer / C# Developer

£40-50K: Guru Careers: We are seeking an experienced Software / C# Developer w...

Neil Pavier: Management Accountant

£45,000 - £55,000: Neil Pavier: Are you looking for your next opportunity for ...

Sheridan Maine: Commercial Accountant

£45,000 - £55,000: Sheridan Maine: Are you a newly qualified ACA/ACCA/ACMA qua...

Laura Norton: Project Accountant

£50,000 - £60,000: Laura Norton: Are you looking for an opportunity within a w...

Day In a Page

Abuse - and the hell that came afterwards

Abuse - and the hell that follows

James Rhodes on the extraordinary legal battle to publish his memoir
Why we need a 'tranquility map' of England, according to campaigners

It's oh so quiet!

The case for a 'tranquility map' of England
'Timeless fashion': It may be a paradox, but the industry loves it

'Timeless fashion'

It may be a paradox, but the industry loves it
If the West needs a bridge to the 'moderates' inside Isis, maybe we could have done with Osama bin Laden staying alive after all

Could have done with Osama bin Laden staying alive?

Robert Fisk on the Fountainheads of World Evil in 2011 - and 2015
New exhibition celebrates the evolution of swimwear

Evolution of swimwear

From bathing dresses in the twenties to modern bikinis
Sun, sex and an anthropological study: One British academic's summer of hell in Magaluf

Sun, sex and an anthropological study

One academic’s summer of hell in Magaluf
From Shakespeare to Rising Damp... to Vicious

Frances de la Tour's 50-year triumph

'Rising Damp' brought De la Tour such recognition that she could be forgiven if she'd never been able to move on. But at 70, she continues to flourish - and to beguile
'That Whitsun, I was late getting away...'

Ian McMillan on the Whitsun Weddings

This weekend is Whitsun, and while the festival may no longer resonate, Larkin's best-loved poem, lives on - along with the train journey at the heart of it
Kathryn Williams explores the works and influences of Sylvia Plath in a new light

Songs from the bell jar

Kathryn Williams explores the works and influences of Sylvia Plath
How one man's day in high heels showed him that Cannes must change its 'no flats' policy

One man's day in high heels

...showed him that Cannes must change its 'flats' policy
Is a quiet crusade to reform executive pay bearing fruit?

Is a quiet crusade to reform executive pay bearing fruit?

Dominic Rossi of Fidelity says his pressure on business to control rewards is working. But why aren’t other fund managers helping?
The King David Hotel gives precious work to Palestinians - unless peace talks are on

King David Hotel: Palestinians not included

The King David is special to Jerusalem. Nick Kochan checked in and discovered it has some special arrangements, too
More people moving from Australia to New Zealand than in the other direction for first time in 24 years

End of the Aussie brain drain

More people moving from Australia to New Zealand than in the other direction for first time in 24 years
Meditation is touted as a cure for mental instability but can it actually be bad for you?

Can meditation be bad for you?

Researching a mass murder, Dr Miguel Farias discovered that, far from bringing inner peace, meditation can leave devotees in pieces
Eurovision 2015: Australians will be cheering on their first-ever entrant this Saturday

Australia's first-ever Eurovision entrant

Australia, a nation of kitsch-worshippers, has always loved the Eurovision Song Contest. Maggie Alderson says it'll fit in fine